Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 2011

Chinese Journal of Oncology

Volumn 34, Issue 7, 2012, Pages 538-542

  Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Early diagnosis; Mass screening; Stomach neoplasms

Indexed keywords

PEPSINOGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHINA; CLINICAL EFFECTIVENESS; EARLY DIAGNOSIS; EARLY INTERVENTION; FAMILY HISTORY; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; POPULATION RESEARCH; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; STOMACH SURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; CHINA; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRITIS; GASTRITIS, ATROPHIC; GASTROSCOPY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PEPSINOGEN A; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84865285482     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.07.013     Document Type: Article

References (19)

1. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol, 2008, 9:279-287.
2. Hamashima C, Shibuya D, Yamazaki H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol, 2008, 38:259-267.
3. Ministry of Health and Welfare of Korea. National Cancer Screening Program [EB/OL]. [2012-04-16]. https://ncc.re.kr:8443/english/programs/ progarms03.jsp.
4. Kong SH, Park DJ, Lee HJ, et al. Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea. Jpn J Clin Oncol, 2004, 34:1-7.
5. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol, 2006, 4:709-716.
6. Hallissey MT, Dunn JA, Fielding JW. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scand J Gastroenterol, 1994, 29:1129-1134.
7. Jin B, Wang X, Jin Y, et al. Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. Cancer Invest, 2009, 27:227-233.
8. Vecchi M, Nuciforo P, Romagnoli S, et al. Gene expression analysis of early and advanced gastric cancers. Oncogene, 2007, 26:4284-4294.
9. Rajčevic U, Hudler P, Mijovski G, et al. Assessment of differential expression of oncogenes in adenocarcinoma of stomach with fluorescent labeling and simultaneous amplification of gene transcripts. Radiol Oncol, 2007, 41:174-182.
10. Miki K, Fujishiro M, Kodashima S, et al. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc, 2009, 21:78-81.
11. Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut, 1999, 44:693-697.
12. National Cancer Institute. Stomach (Gastric) Cancer Screening [EB/OL]. [2012-04-16]. http://www.cancer.gov/cancertopics/pdq/screening/gastric/Patient/ page3.